3000 F billion has been requested by president Barack Obama in Congress to allow the acceleration of research and to continue the fight in the most affected countries.
Visiting premises the of U.S. institutes of health (NIH) in Bethesda, a suburb near Washington, Barack Obama invited the US Congress to release a Fund of emergency of more than $ 6 billion, approximately 3 000 billion, to combat Ebola.
For the president of the United States, this is to mobilize more for a final and lasting solution to this epidemic. "We cannot defeat Ebola without additional financing. If we want other countries to continue to mobilise, we must continue to lead the way," he said, recalling that some 3,000 soldiers and American civilians have been deployed in West Africa in the most affected countries.
Recalling that the issue of the financing of the fight against Ebola has been the subject of a consensus between Republicans and Democrats so far, Barack Obama warned against any confusion that may occur between funding of the fight against Ebola and warm ongoing budget discussions.
This inquiry of U.S. president comes at a time when members of Congress are preparing to go on holiday December 12. "This is not a question of policy. It is a matter of common sense. Let's do this. It is a beautiful gift for the anniversary for Americans and for the world", he added.
For Mr. Obama, far from being a simple case, the fight against Ebola is a real challenge for the United States. "We have to eradicate this disease, it is not a virus that we can deal with a few cases here and there. "We cannot lower our guard, not even one moment", he hammered.
The emergency fund championed by the American president will not be only to continue the fight on the ground, but also to accelerate the ongoing search for a therapeutic vaccine. Co-developed by the Institute of Allergy and infectious diseases and the British laboratory Glaxo Smith Kline, said vaccine, according to the initial results made public a few days ago triggered a good immune response. "No potential Ebola vaccine had gone as far. "This is excellent news," he welcomed.
